Abstract:Background/Objectives: Breast cancer, a leading health threat affecting millions worldwide, requires effective therapeutic interventions. Celastrol (CEL), despite its antitumor potential, is limited by poor solubility and stability. This study aimed to enhance CEL's efficacy by encapsulating it within glycyrrhizic acid (GA)-modified lipid calcium carbonate (LCC) nanoparticles for targeted breast cancer therapy. Methods: The 4T1 mouse breast cancer cells were used for the study. GA-LCC-CEL nanoparticles were prepared using a gas diffusion method and a thin-film dispersion method. GA-LCC-CEL were characterized using the zeta-potential, dynamic light scattering and transmission electron microscope (TEM). The in vitro release behavior of nanoparticles was assessed using the in vitro dialysis diffusion method. Cellular uptake was examined using flow cytometry and confocal microscopy. Intracellular ROS and Rhodamine 123 levels were observed under fluorescence microscopy. MTT and colony formation assays assessed cytotoxicity and proliferation, and apoptosis was analyzed by Annexin V-FITC/PI staining. Wound healing and transwell assays evaluated migration, and Western blotting confirmed protein expression changes related to apoptosis and migration. Results: GA-LCC-CEL nanoparticles displayed a well-defined core-shell structure with a uniform size distribution. They showed enhanced anti-proliferative and pro-apoptotic effects against 4T1 cells and significantly reduced breast cancer cell invasion and migration. Additionally, GA-LCC-CEL modulated epithelial-mesenchymal transition (EMT) protein expression, downregulating Snail and ZEB1, and upregulating E-cadherin. Conclusions: GA-LCC-CEL nanoparticles represent a promising targeted drug delivery approach for breast cancer, enhancing CEL's antitumor efficacy and potentially inhibiting cancer progression by modulating EMT-related proteins.

Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer

Celastrol-conjugated carboxylmethyl chitosan for oral treatment of diet-induced obesity

Hepatoma-targeting and reactive oxygen species-responsive chitosan-based polymeric micelles for delivery of celastrol

Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel

Celastrol Loaded Nanoparticles With ROS-Response and ROS-Inducer for the Treatment of Ovarian Cancer

The Cellular Labeling and Ph-Sensitive Responsive-Drug Release of Celastrol in Cancer Cells Based on Cys-CdTe QDs

Synthesis of a celastrol derivative as a cancer stem cell inhibitor through regulation of the STAT3 pathway for treatment of ovarian cancer

Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy

Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma

Oxaliplatin-incorporated Micelles Eliminate Both Cancer Stem-Like and Bulk Cell Populations in Colorectal Cancer

Cellular Uptake and Cytotoxicity of Shell Crosslinked Stearic Acid-Grafted Chitosan Oligosaccharide Micelles Encapsulating Doxorubicin.

Preparation of polydopamine-modified celastrol nanosuspension and its anti-liver cancer activity in vitro

Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer

Hyaluronic acid-zein shell-core biopolymer nanoparticles enhance hepatocellular carcinoma therapy of celastrol via CD44-mediated cellular uptake

Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway

The β-glucan nanotube carrier achieves detoxification and efficacy enhancement of celastrol in intrahepatic cholangiocarcinoma therapy by increasing targeted controlled release and macrophage polarization

Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin.

Design, synthesis, and evaluation of antitumor activity of novel C‐6 sulfhydryl‐substituted and 20‐substituted derivatives of celastrol

PEGylated Chitosan-Based Polymer Micelle As an Intracellular Delivery Carrier for Anti-Tumor Targeting Therapy.

Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application

Synthesis and Antitumor Activity of Doxorubicin Conjugated Stearic Acid-G-chitosan Oligosaccharide Polymeric Micelles